-
2
-
-
0030607603
-
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
-
Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. The Lancet. 1996; 348: 1472-7.
-
(1996)
The Lancet
, vol.348
, pp. 1472-1477
-
-
Hardcastle, J.D.1
Chamberlain, J.O.2
Robinson, M.H.E.3
Moss, S.M.4
Amar, S.S.5
Balfour, T.W.6
-
4
-
-
76549120768
-
Colorectal cancer screening
-
Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, et al. Colorectal cancer screening. Journal of the National Comprehensive Cancer Network. 2010; 8: 8-61.
-
(2010)
Journal of the National Comprehensive Cancer Network
, vol.8
, pp. 8-61
-
-
Burt, R.W.1
Barthel, J.S.2
Dunn, K.B.3
David, D.S.4
Drelichman, E.5
Ford, J.M.6
-
5
-
-
79952815104
-
Stool DNA screening for colorectal cancer: Opportunities to improve value with next generation tests
-
Kisiel JB, Ahlquist DA. Stool DNA screening for colorectal cancer: opportunities to improve value with next generation tests. Journal of clinical gastroenterology. 2011; 45: 301.
-
(2011)
Journal of Clinical Gastroenterology
, vol.45
, pp. 301
-
-
Kisiel, J.B.1
Ahlquist, D.A.2
-
8
-
-
67449128445
-
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
-
Hellebrekers DMEI, Lentjes MHFM, Van Den Bosch SM, Melotte V, Wouters KAD, Daenen KLJ, et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clinical Cancer Research. 2009; 15: 3990-7.
-
(2009)
Clinical Cancer Research
, vol.15
, pp. 3990-3997
-
-
Hellebrekers, D.M.E.I.1
Lentjes, M.H.F.M.2
Van Den Bosch, S.M.3
Melotte, V.4
Wouters, K.A.D.5
Daenen, K.L.J.6
-
9
-
-
67349175004
-
Long-range epigenetic silencing at 2q14. 2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease
-
Mayor R, Casadomé L, Azuara D, Moreno V, Clark S, Capella G, et al. Long-range epigenetic silencing at 2q14. 2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. British journal of cancer. 2009; 100: 1534-9.
-
(2009)
British Journal of Cancer
, vol.100
, pp. 1534-1539
-
-
Mayor, R.1
Casadomé, L.2
Azuara, D.3
Moreno, V.4
Clark, S.5
Capella, G.6
-
10
-
-
67649635452
-
N-Myc downstream-regulated gene 4 (NDRG4): A candidate tumor suppressor gene and potential biomarker for colorectal cancer
-
Melotte V, Lentjes MHFM, van den Bosch SM, Hellebrekers DMEI, de Hoon JPJ, Wouters KAD, et al. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Journal of the National Cancer Institute. 2009; 101: 916-27.
-
(2009)
Journal of the National Cancer Institute
, vol.101
, pp. 916-927
-
-
Melotte, V.1
Lentjes, M.H.F.M.2
van den Bosch, S.M.3
Hellebrekers, D.M.E.I.4
de Hoon, J.P.J.5
Wouters, K.A.D.6
-
11
-
-
34248193319
-
Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking
-
Bakowska JC, Jupille H, Fatheddin P, Puertollano R, Blackstone C. Troyer syndrome protein spartin is mono-ubiquitinated and functions in EGF receptor trafficking. Molecular biology of the cell. 2007; 18: 1683-92.
-
(2007)
Molecular Biology of the Cell
, vol.18
, pp. 1683-1692
-
-
Bakowska, J.C.1
Jupille, H.2
Fatheddin, P.3
Puertollano, R.4
Blackstone, C.5
-
12
-
-
85027949861
-
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
-
Lind G, Raiborg C, Danielsen S, Rognum T, Thiis-Evensen E, Hoff G, et al. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene. 2011; 30: 3967-78.
-
(2011)
Oncogene
, vol.30
, pp. 3967-3978
-
-
Lind, G.1
Raiborg, C.2
Danielsen, S.3
Rognum, T.4
Thiis-Evensen, E.5
Hoff, G.6
-
13
-
-
0038610890
-
Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer
-
Klaassen CHW, Jeunink MAF, Prinsen CFM, Ruers TJM, Tan AC, Strobbe LJA, et al. Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer. Clinical chemistry. 2003; 49: 1185-7.
-
(2003)
Clinical Chemistry
, vol.49
, pp. 1185-1187
-
-
Klaassen, C.H.W.1
Jeunink, M.A.F.2
Prinsen, C.F.M.3
Ruers, T.J.M.4
Tan, A.C.5
Strobbe, L.J.A.6
-
14
-
-
77951633198
-
Molecular detection of colorectal neoplasia
-
Ahlquist DA. Molecular detection of colorectal neoplasia. Gastroenterology. 2010; 138: 2127-39.
-
(2010)
Gastroenterology
, vol.138
, pp. 2127-2139
-
-
Ahlquist, D.A.1
-
15
-
-
66349102768
-
Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer
-
Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer research. 2009; 69: 4691.
-
(2009)
Cancer Research
, vol.69
, pp. 4691
-
-
Glöckner, S.C.1
Dhir, M.2
Yi, J.M.3
McGarvey, K.E.4
van Neste, L.5
Louwagie, J.6
-
16
-
-
68449085638
-
Promoter DNA methylation of oncostatin m receptor-β as a novel diagnostic and therapeutic marker in colon cancer
-
Kim MS, Louwagie J, Carvalho B, sive Droste JST, Park HL, Chae YK, et al. Promoter DNA methylation of oncostatin m receptor-β as a novel diagnostic and therapeutic marker in colon cancer. PLoS One. 2009; 4: e6555.
-
(2009)
PLoS One
, vol.4
-
-
Kim, M.S.1
Louwagie, J.2
Carvalho, B.3
sive Droste, J.S.T.4
Park, H.L.5
Chae, Y.K.6
-
17
-
-
53749091845
-
Stool DNA and occult blood testing for screen detection of colorectal neoplasia
-
Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Annals of internal medicine. 2008; 149: 441-50.
-
(2008)
Annals of Internal Medicine
, vol.149
, pp. 441-450
-
-
Ahlquist, D.A.1
Sargent, D.J.2
Loprinzi, C.L.3
Levin, T.R.4
Rex, D.K.5
Ahnen, D.J.6
-
18
-
-
68149181469
-
Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients
-
Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients. Diseases of the Colon & Rectum. 2009; 52: 1452.
-
(2009)
Diseases of the Colon & Rectum
, vol.52
, pp. 1452
-
-
Baek, Y.H.1
Chang, E.2
Kim, Y.J.3
Kim, B.K.4
Sohn, J.H.5
Park, D.I.6
-
19
-
-
55349115380
-
A simplified, noninvasive stool DNA test for colorectal cancer detection
-
Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, et al. A simplified, noninvasive stool DNA test for colorectal cancer detection. The American journal of gastroenterology. 2008; 103: 2862-70.
-
(2008)
The American Journal of Gastroenterology
, vol.103
, pp. 2862-2870
-
-
Itzkowitz, S.1
Brand, R.2
Jandorf, L.3
Durkee, K.4
Millholland, J.5
Rabeneck, L.6
-
21
-
-
78149260396
-
Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: A preliminary report in Korean patients
-
Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, et al. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Hepato-gastroenterology. 2010; 57: 720-7.
-
(2010)
Hepato-gastroenterology
, vol.57
, pp. 720-727
-
-
Chang, E.1
Park, D.I.2
Kim, Y.J.3
Kim, B.K.4
Park, J.H.5
Kim, H.J.6
-
22
-
-
84858308403
-
Stool DNA screening for colorectal neoplasia: Biological and technical basis for high detection rates
-
Berger BM, Ahlquist DA. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology-Journal of the RCPA. 2012; 44: 80.
-
(2012)
Pathology-Journal of the RCPA
, vol.44
, pp. 80
-
-
Berger, B.M.1
Ahlquist, D.A.2
-
23
-
-
84856391668
-
Quantification of methylated markers with a multiplex methylation-specific technology
-
Zou H, Allawi H, Cao X, Domanico M, Harrington J, Taylor WR, et al. Quantification of methylated markers with a multiplex methylation-specific technology. Clinical chemistry. 2012; 58: 375-83.
-
(2012)
Clinical Chemistry
, vol.58
, pp. 375-383
-
-
Zou, H.1
Allawi, H.2
Cao, X.3
Domanico, M.4
Harrington, J.5
Taylor, W.R.6
-
24
-
-
84863456744
-
Digital Detection of Multiple Minority Mutants in Stool DNA for Noninvasive Colorectal Cancer Diagnosis
-
Deng L, Qi Z, Zou B, Wu H, Huang H, Kajiyama T, et al. Digital Detection of Multiple Minority Mutants in Stool DNA for Noninvasive Colorectal Cancer Diagnosis. Analytical chemistry. 2012; 84: 5645-52.
-
(2012)
Analytical Chemistry
, vol.84
, pp. 5645-5652
-
-
Deng, L.1
Qi, Z.2
Zou, B.3
Wu, H.4
Huang, H.5
Kajiyama, T.6
-
25
-
-
69449105785
-
Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification
-
Ostwald C, Linnebacher M, Weirich V, Prall F. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. International journal of oncology. 2009; 35: 321.
-
(2009)
International Journal of Oncology
, vol.35
, pp. 321
-
-
Ostwald, C.1
Linnebacher, M.2
Weirich, V.3
Prall, F.4
-
26
-
-
84870018290
-
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection
-
Bosch LJW, Mongera S, sive Droste JST, Oort FA, van Turenhout ST, Penning MT, et al. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection. Cellular Oncology. 2012;: 1-7.
-
(2012)
Cellular Oncology
, pp. 1-7
-
-
Bosch, L.J.W.1
Mongera, S.2
sive Droste, J.S.T.3
Oort, F.A.4
van Turenhout, S.T.5
Penning, M.T.6
|